SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO)
TWD 89.0
(3.97%)
TWD 89.0
(3.97%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 281.85 Million TWD | 18.31% |
| 2022 | 238.22 Million TWD | 41.31% |
| 2021 | 168.58 Million TWD | -35.75% |
| 2020 | 262.37 Million TWD | 30.79% |
| 2019 | 200.61 Million TWD | 34.18% |
| 2018 | 149.5 Million TWD | 47.32% |
| 2017 | 101.48 Million TWD | -46.07% |
| 2016 | 188.17 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 74.61 Million TWD | 21.02% |
| 2024 Q2 | 108.14 Million TWD | 44.95% |
| 2023 FY | 281.85 Million TWD | 18.31% |
| 2023 Q1 | 81.12 Million TWD | 32.99% |
| 2023 Q2 | 59.02 Million TWD | -27.25% |
| 2023 Q4 | 61.65 Million TWD | -22.99% |
| 2023 Q3 | 80.05 Million TWD | 35.64% |
| 2022 Q1 | 13.63 Million TWD | 89.42% |
| 2022 Q4 | 60.99 Million TWD | -28.01% |
| 2022 Q3 | 84.73 Million TWD | 51.66% |
| 2022 Q2 | 55.87 Million TWD | 309.87% |
| 2022 FY | 238.22 Million TWD | 41.31% |
| 2021 Q3 | 34.49 Million TWD | 0.0% |
| 2021 FY | 168.58 Million TWD | -35.75% |
| 2021 Q4 | 7.19 Million TWD | -79.14% |
| 2020 FY | 262.37 Million TWD | 30.79% |
| 2019 FY | 200.61 Million TWD | 34.18% |
| 2018 FY | 149.5 Million TWD | 47.32% |
| 2017 FY | 101.48 Million TWD | -46.07% |
| 2016 FY | 188.17 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sagittarius Life Science Corp | -64.37 Million TWD | 537.82% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | -1066.505% |
| VBI | -16.13 Million TWD | 1847.155% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | 12610.031% |
| Visgeneer Inc. | -21.15 Million TWD | 1432.062% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | -249.327% |
| EirGenix Inc. | -1.03 Billion TWD | 127.312% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | -345.016% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | 490.938% |
| RBC Bioscience Corporation | 14.53 Million TWD | -1838.586% |
| BiOptic Inc. | 44.05 Million TWD | -539.8% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | 596.662% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | 549.645% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | 528.215% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | 499.324% |
| Level Biotechnology Inc. | 67.55 Million TWD | -317.236% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | 431.808% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 269.554% |
| GlycoNex Incorporation | -259.86 Million TWD | 208.461% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 222.926% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | 719.426% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 431.613% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 146.811% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 68.501% |
| Neith Corporation | -48.85 Million TWD | 676.925% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 123.22% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | 4364.009% |
| Enimmune corporation | -243.47 Million TWD | 215.762% |
| TaiRx, Inc. | -214.69 Million TWD | 231.28% |
| CHO Pharma, Inc. | -268.99 Million TWD | 204.778% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 125.697% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 401.975% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 259.652% |
| Lukas Biomedical Inc. | -43.56 Million TWD | 747.041% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 140.605% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 15.634% |
| NaviFUS Corp. | -76.42 Million TWD | 468.789% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 399.985% |
| Sinew Pharma Inc. | -186.25 Million TWD | 251.327% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | 516.342% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | -76.359% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 175.035% |
| AP Biosciences Inc | -347.47 Million TWD | 181.113% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 122.857% |
| 3D Global Biotech Inc. | -62.85 Million TWD | 548.429% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | 10080.559% |
| Intech Biopharm Corporation | -304.39 Million TWD | 192.594% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 125.702% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | 779.454% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 266.229% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 16.546% |
| TCI GENE Inc. | 10.04 Million TWD | -2704.767% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 321.482% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 190.595% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 232.821% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | -8107.659% |
| PharmaEngine, Inc. | 277.18 Million TWD | -1.684% |
| Savior Lifetec Corporation | -2.42 Million TWD | 11746.736% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 261.335% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 113.487% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | 328.861% |
| Acepodia, Inc. | -435.97 Million TWD | 164.649% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 157.761% |